80 related articles for article (PubMed ID: 17907967)
1. Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.
Mitsuhashi J; Tsukahara S; Suzuki R; Oh-hara Y; Nishi S; Hosoyama H; Katayama K; Noguchi K; Minowa S; Shibata H; Ito Y; Hatake K; Aiba K; Takahashi S; Sugimoto Y
Hum Gene Ther; 2007 Oct; 18(10):895-906. PubMed ID: 17907967
[TBL] [Abstract][Full Text] [Related]
2. In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate.
Mitsuhashi J; Hosoyama H; Tsukahara S; Katayama K; Noguchi K; Ito Y; Hatake K; Aiba K; Takahashi S; Sugimoto Y
J Gene Med; 2010 Jul; 12(7):596-603. PubMed ID: 20533531
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.
Takahashi S; Aiba K; Ito Y; Hatake K; Nakane M; Kobayashi T; Minowa S; Shibata H; Mitsuhashi J; Tsukahara S; Ishikawa E; Suzuki R; Tsuruo T; Sugimoto Y
Cancer Sci; 2007 Oct; 98(10):1609-16. PubMed ID: 17683514
[TBL] [Abstract][Full Text] [Related]
5. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.
Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T
Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy using anticancer drug-resistance genes].
Sugimoto Y
Gan To Kagaku Ryoho; 1999 Jan; 26(1):1-9. PubMed ID: 9987494
[TBL] [Abstract][Full Text] [Related]
8. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
9. [Gene therapy for breast cancer].
Takahashi S; Hatake K; Sugimoto Y
Gan To Kagaku Ryoho; 2003 Apr; 30(4):468-77. PubMed ID: 12722676
[TBL] [Abstract][Full Text] [Related]
10. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.
Buss EC; Laufs S; Naundorf S; Kuehlcke K; Nagy KZ; Zeller WJ; Fruehauf S
Cytotherapy; 2006; 8(6):562-9. PubMed ID: 17148033
[TBL] [Abstract][Full Text] [Related]
11. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
Aksentijevich I; Cardarelli CO; Pastan I; Gottesman MM
Clin Cancer Res; 1996 Jun; 2(6):973-80. PubMed ID: 9816258
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene.
Hanania EG; Fu S; Zu Z; Hegewisch-Becker S; Korbling M; Hester J; Durett A; Andreeff M; Mechetner E; Holzmayer T
Gene Ther; 1995 Jun; 2(4):285-94. PubMed ID: 7552989
[TBL] [Abstract][Full Text] [Related]
13. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells.
Knipper R; Kuehlcke K; Schiedlmeier B; Hildinger M; Lindemann C; Schilz AJ; Fauser AA; Fruehauf S; Zeller WJ; Ostertag W; Eckert HG; Baum C
Gene Ther; 2001 Feb; 8(3):239-46. PubMed ID: 11313796
[TBL] [Abstract][Full Text] [Related]
14. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.
Moscow JA; Huang H; Carter C; Hines K; Zujewski J; Cusack G; Chow C; Venzon D; Sorrentino B; Chiang Y; Goldspiel B; Leitman S; Read EJ; Abati A; Gottesman MM; Pastan I; Sellers S; Dunbar C; Cowan KH
Blood; 1999 Jul; 94(1):52-61. PubMed ID: 10381498
[TBL] [Abstract][Full Text] [Related]
15. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital.
Takahashi S; Ito Y; Hatake K; Sugimoto Y
Breast Cancer; 2006; 13(1):8-15. PubMed ID: 16518057
[TBL] [Abstract][Full Text] [Related]
17. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.
Schilz AJ; Schiedlmeier B; Kühlcke K; Fruehauf S; Lindemann C; Zeller WJ; Grez M; Fauser AA; Baum C; Eckert HG
Mol Ther; 2000 Dec; 2(6):609-18. PubMed ID: 11124062
[TBL] [Abstract][Full Text] [Related]
18. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies.
Hibino H; Tani K; Ikebuchi K; Wu MS; Sugiyama H; Nakazaki Y; Tanabe T; Takahashi S; Tojo A; Suzuki S; Tanioka Y; Sugimoto Y; Nakahata T; Asano S
Blood; 1999 May; 93(9):2839-48. PubMed ID: 10216078
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy using anticancer drug-resistance genes].
Sugimoto Y
Hum Cell; 1999 Sep; 12(3):115-23. PubMed ID: 10695018
[TBL] [Abstract][Full Text] [Related]
20. Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells.
Schiedlmeier B; Buss EC; Veldwijk MR; Zeller WJ; Fruehauf S
Hum Gene Ther; 1999 Jun; 10(9):1443-52. PubMed ID: 10395370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
